The need for transplants continues to exceed organ and tissue donor availability. Although recent surgical advances have resulted in successful transplants using very small pediatric donors, including neonates, the actual practice of neonatal organ donation after circulatory determination of death (DCDD) remains uncommon.
I n the past, neonates have not been eligible for organ donation owing to the technical difficulties and the high risk for graft complication involved with transplant of their small organs. [1] [2] [3] [4] Donation after neurologic determination of death occurs while optimal organ perfusion is maintained by continued medical therapies to the time of organ recovery. Despite established criteria for the diagnosis of death by neurologic criteria in term neonates, organ and tissue donation after neurologic determination of death rarely occurs in this population. [5] [6] [7] At present, fewer than 1% of all organ or tissue donations come from donors younger than 1 year. 8 However,
ongoing organ shortages coupled with improved technology and surgical techniques have led to a renewed interest in neonates as potential candidates for organ donation after circulatory determination of death (DCDD).
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Donation after circulatory determination of death occurs in cases of severe life-limiting illness after a decision is made to withdraw life-sustaining interventions and allow death to occur. The period from withdrawal of these interventions to the time of death is termed warm ischemic time (WIT) and must be relatively short for successful DCDD. Many critically ill neonates die in the neonatal intensive care unit (NICU) after withdrawal of life-sustaining interventions, 10-12 but organ donation is frequently not considered before this time, resulting in a missed opportunity for DCDD. Unfortunately, these missed opportunities are not unique to neonates. 13, 14 Although most DCDD has occurred in adults, pediatric donors increasingly undergo DCDD, including neonates. 15 At Primary Children's Hospital, Salt Lake City, Utah, a number of neonates have been successfully referred for DCDD and have donated en bloc kidneys for transplant in older patients. 3, 4 Recent studies have shown that en bloc pediatric kidney transplants have clinical outcomes similar to those of sizematched recipients of single adult kidneys. [16] [17] [18] Given this experience, we hypothesized that many neonates who die in the NICU could serve as organ and/or tissue donors if appropriately identified and if their families are counseled regarding the opportunity to participate in DCDD.
Methods
To determine the percentage of deaths of neonates eligible for DCDD, we performed a retrospective analysis of deaths in our NICU from January 1, 2010, through May 7, 2013. We reviewed the frequency with which neonates underwent evaluation for DCDD and whether organ donation was successfully completed. For neonates in whom DCDD did not occur, we reviewed records to determine the reasons for ineligibility. Primary Children's Hospital, an Intermountain Healthcare facility, operates a large level IV referral NICU serving patients in the Mountain West region. Intermountain Donor Services (IDS) is the regional organ procurement organization (OPO) and has provided the opportunity for DCDD in pediatric donors as small as 2 kg since 2010. We reviewed the records of neonates who died in the hospital during the study period. Although patients ranged in age from less than 1 day to 1 year, for simplicity we have used the term neonate to describe all these patients. Deidentified data were collected prospectively on all admissions as part of the Children's Hospital Neonatal Database for which Primary Children's Hospital is a member. The institutional review board for Primary Children's Hospital approved this study and waived the need for informed consent for medical record review.
Potential Eligibility for Organ Donation
Deaths were reviewed from January 12 through July 1, 2014, to determine potential eligibility for organ/tissue donation as per IDS criteria. Evaluation of criteria for neurologic determination of death was performed when deemed appropriate by the attending physician. Minimum inclusion criteria for DCDD include a weight exceeding 2 kg, reliance on life-sustaining medical interventions, and a WIT of less than 90 minutes. Although additional exclusions to donation may apply (eg, bacteremia, renal anomalies), these exclusions are not considered by IDS to be absolute. Patients must be identified and referred to the OPO before withdrawal of life-sustaining interventions to allow for evaluation, preparation, and monitoring. For the purpose of this study, a referral made before withdrawal of these interventions was considered a timely referral, and any referral after withdrawal or any failure to refer was considered a late referral. For small (patient weight, 2-5 kg) pediatric DCDD, IDS currently provides the possibility of en bloc renal transplant, hepatocyte donation, and heart valve transplant ( Figure) . When minimum eligibility criteria are met and timely OPO referral is made, the transplant surgeon and IDS review each case and determine final eligibility for donation.
Review of OPO Referrals
In addition to records from the Children's Hospital Neonatal Database, we reviewed OPO records to determine whether donation occurred and the reasons for ineligibility (if applicable). Demographic characteristics (eg, gestational age, weight, and cause of death) were evaluated between neonates with timely and late OPO referrals. The last measured aspartate transaminase, alanine transaminase, and creatinine concentrations were analyzed as surrogate markers of liver and kidney function at the time of death. In neonates with known chromosomal abnormalities or major defects involving 2 or more organ systems, these were evaluated together as multiple anomalies.
At a Glance
• Despite their small size, neonates frequently exceed the minimum criteria for participation in organ donation at the time of death. • Adults receiving en bloc kidney transplants from neonatal donors have excellent results, and experience with these challenging cases is increasing.
• Of 136 total neonatal intensive care unit deaths, 60 (44.1%) met criteria for donation after circulatory determination of death; however, less than 10% were appropriately referred to the regional organ procurement organization (OPO) for evaluation.
• Despite the potential for organ donation as part of neonatal end-of-life care, communication with the OPO frequently occurs after withdrawal of life-sustaining interventions, after death, or not at all.
Statistical Analysis
Characteristics of potential DCDD candidates were summarized using median (interquartile range) data and counts depending on variable distributions. Summaries were stratified by timely and late OPO referrals. We compared the cause of death across OPO referral timeliness using a Fisher exact test and continuous variables using an exact Wilcoxon rank sum test. Statistical analysis was conducted using R (version 3.03 [http://www.r-project.org]). Significance was defined as P < .05.
Results

Study Cohort
One hundred thirty-six deaths occurred during the study period. Of these, 76 neonates (55.9%) weighed more than 2 kg (60 sue recovery for donation (3 kidney donations and 1 tissue donation). For potentially eligible neonates, the most common cause of death was profound central nervous system injury and/or encephalopathy (n = 17), followed by multiple anomalies (n = 14). The median WIT was 48 minutes. No deaths occurred based on the neurologic criteria.
OPO Referral
Sixty neonates had withdrawal of life-sustaining interventions and weighed more than 2 kg, thereby meeting criteria for referral to the OPO. Only 11 neonates (8.1%) had timely referral; in all 11 cases, medical records indicated that the family inquired about and actively pursued organ donation. Of the timely OPO referrals, 4 neonates were ineligible on further evaluation by the OPO (3 had congenital anomalies and 1 had total intestinal aganglionosis and did not require mechanical ventilation for life support), 4 families declined further participation in the DCDD process, and 3 neonates donated en bloc kidneys. Forty-nine neonates (36.0%) had late OPO referral. Of these, 26 neonates were referred before their death but after withdrawal of life-sustaining interventions, making them ineligible. One neonate donated heart valves at the time of autopsy despite being referred too late for organ donation. For the remaining 23 neonates, communication with the OPO occurred after death or not at all. We found no statistically significant differences in most demographic characteristics, including weight, primary diagnosis, WIT, aspartate transaminase and alanine transaminase concentrations, and gestational age between patients with timely OPO referrals vs those with late referrals. However, the group with timely OPO referrals had a lower median creatinine level (0.4 mg/dL [to convert to micromoles per liter, multiply by 88.4) at the time of death compared with the group with late or no referral (0.6 mg/dL) (P = .03) (Table) .
Discussion
We found that more than one-third of all NICU deaths met the minimum criteria for DCDD. Of these, only a small percentage were identified and referred to the OPO early enough to undergo evaluation for DCDD. Although our sample size was small, our DCDD rate for timely referral of neonates was 3 of 11 neonates (27%). Assuming a similar rate for all deaths meeting minimum criteria, we estimate that as many as 4.7 neonatal organ/tissue donations per year (approximately 12% of all deaths) could occur from our single-center NICU population. This estimate is about 5.4-fold greater than our current rate of 0.86 donations per year. We may have underestimated the potential organ donors given that previously published rates of pediatric donor consent range from 40% to 70%. 19 
Supporting Studies
Our findings support those of several recent studies looking at the potential for neonatal DCDD. Labrecque et al 20 19 suggests that the projected contribution of donor kidneys may be equivalent to or even exceed projections from broad implementation of DCDD programs in pediatric ICUs. 15, 21, 22 The minimum weight and WIT thresholds for successful DCDD are subject to debate and vary among OPOs. Published reports (using the definition of WIT as the time from extubation to initiation of cold perfusion) suggest that the optimal WIT is less than 60 minutes for kidney transplants. 23 In addition to WIT criteria, greater donor weight and height have been associated with an improved rate of kidney recovery. 24 However, graft survival is being achieved with donors as small as 1.9 kg, 25 and many OPOs are accepting WIT ranging from 90
to 120 minutes with good results. 19 In addition to variation in minimum weight and WIT among programs, the period after declaration of death but before initiation of the procurement operation varies. The Institute of Medicine 26 has stated that the time should be no shorter than 2 minutes to ensure that autoresuscitation does not occur, but no longer than 5 minutes. Standardized DCDD protocols in small infants and children are needed because the practice varies nationally.
Potential Neonatal Contribution to the Donor Pool
Neonatal kidneys are almost always transplanted into adult recipients. The grafts grow with time and have good results in adults. Larger donor weight and shorter WIT may provide for potential liver, lung, intestine, 27 and even heart DCDD in the appropriately defined, size-matched pediatric population.
28,29
However, the number of small pediatric patients on transplant waiting lists is small compared with the more than 100 000 adults on the kidney transplant waiting list. Although nearly half of all neonatal deaths identified in our study population met criteria for OPO referral, fewer than 10% were referred before withdrawal of life-sustaining interventions. Inadequate weight has been the primary reason for exclusion of neonates from participation in DCDD. This study is, to our knowledge, the first to identify inadequate OPO referral by health care practitioners as an important hurdle to neonatal participation in organ donation. Although specific reasons for late OPO referral could not be assessed in our study, similar problems with identification and timely referral in adult and older pediatric populations have been well described. 30 Hospitals have worked to better recognize imminent death, and many have instituted clinical referral triggers to optimize timely OPO referrals. 30 However, clinical triggers or scoring tools specific to the unique developmental limitations of neonates have not yet been established.
Even in large academic centers with active transplant programs, many physicians have limited understanding of the OPO guidelines. 31 We speculate that many practitioners in the NICU have misconceptions about organ donation, lack of familiarity with the DCDD process, and relatively little experience with counseling families to discuss organ donation. In addition, practitioners are likely unaware of recent advances in neonatal kidney transplantation and/or rely on outdated donation criteria. In our study, we identified a family's request as a critical step for timely OPO referral, suggesting that organ donation is unlikely to occur in our NICU unless the family initiates the process.
Outcomes of Transplanted Neonatal Organs, Cells, and Tissues
Because of the size of kidneys from small pediatric donors (weight <5 kg), outcomes are improved when these kidneys are transplanted en bloc. 24 Despite a slightly higher risk for graft thrombosis, successful kidney transplant has occurred from donors as small as 1.9 kg. [32] [33] [34] [35] [36] [37] [38] En bloc kidneys from small pediatric donors have similar rates of graft survival and function compared with those from larger traditional donors and superior outcomes compared with those from deceased to expanded criteria donors. 32, 39, 40 Although most small pediatric kidneys are allocated to adults, children are likely to benefit from improved use of neonatal kidneys. 15 Short-term follow-up of small pediatric kidneys transplanted to pediatric recipients has shown similar good outcomes. 32 Another potential benefit of early referral and evaluation of the neonatal population for potential donation is the possibility of hepatocyte donation. Cytonet, LLC processes donated livers and isolates hepatocytes that are infused into the portal vein of infants with congenital urea cycle defects as a bridge to transplant. Clinical trials of this technology are currently under way. 41 
Potential DCDD Identification and OPO Referral in Neonates
Although the timeliness of OPO referral may vary, it must occur before the withdrawal of life-sustaining interventions. Intermountain Donor Services has optimized their approach to mobilizing resources for rapid DCDD and has achieved successful DCDD within 90 minutes of referral. In the 3 cases of successful kidney donation in our study, IDS referral occurred 3 hours 14 minutes, 1 hour 25 minutes, and 19 hours 6 minutes before the withdrawal of life-sustaining interventions.
In pediatric ICUs, certain factors have been identified as being associated with higher participation in organ donation, including the presence of a level I trauma program or pediatric critical care medicine fellowship program. 42 In addition, parental exposure to information about organ donation before their child's death, the allotment of sufficient time to discuss organ donation before withdrawal of life-sustaining interventions, and the active involvement of a practitioner from the child's health care team are associated with increased participation in organ donation. 43 On the other hand, a lack of confidence in the donation process, misperceptions of cultural viewpoints on organ donation, and concern about differing sion with families about organ donation when their newborn's death is imminent will likely increase participation and improve the end-of-life experience for families who can find comfort in allowing their child to give life to others. Although one-third of the deaths in our study met the minimum criteria for potential DCDD, meeting a minimum weight threshold and WIT does not equate to successful organ transplants. End-organ function, coexisting conditions (eg, syndromes, sepsis), family wishes, and surgeon availability all affect the number of potential candidates who actually become donors. At present, only a single center (University of California, Davis) of which we are aware accepts kidney donations from donors as small as 2 kg. Despite the lack of resources, transplant surgeon availability has not been a limiting factor in DCDD participation for our population to date. However, a scarcity of additional referral sites for neonatal donors will become problematic if OPO referrals increase and more NICUs begin to participate in DCDD without a coexisting increase in surgical expertise and transplant centers willing to use neonatal organs. Until consistent, timely OPO referral occurs throughout multiple NICUs in multiple regions, the true potential and challenges of neonatal organ donation can only be speculated.
Study Limitations
This study is limited by its retrospective nature and the experience of a single center. Our level IV referral NICU has a high rate of medical complexity and acuity that may limit translation of our findings to other centers. In addition, OPO referral was the only available measure to assess consideration of organ donation for any given patient. In some cases, OPO referral may have occurred late because organ donation was discussed and the families declined participation. Although we did not find a difference in most patient characteristics between timely and late referrals, our sample size was small and therefore may not have detected some clinically important differences. We noted an overall higher median creatinine level in the late referral group, including 2 neonates with intrinsic kidney disease. Although this variable may have contributed to a lower OPO referral rate in our study, the absolute creatinine level is not the sole determinant of transplant eligibility.
Higher creatinine levels should not preclude OPO referral because kidneys tend to recover after transplant, even in the setting of acute kidney injury in the donor.
Additional Considerations
Neonatal DCDD invokes unique ethical and emotional responses that have been described previously. 45 Health care practitioners must have a better understanding of the process of DCDD and adequately communicate this information with families. Families wishing to participate in DCDD must realize that the death environment in the NICU will be altered once their child undergoes withdrawal of lifesustaining interventions. Their child will require continued invasive monitoring after withdrawal of the interventions, and the immediacy of the organ recovery process will limit the amount of time they have to spend with their dying child. Throughout this process, the medical and transplant teams must realize that the child and family need to remain the priority. Although pediatric (including neonatal) DCDD has unique ethical considerations, a recent American Academy of Pediatric Bioethics Policy Statement has supported the entire process, emphasizing that organ donation should be undertaken in an ethically rigorous manner. 46 We believe that part of this ethical rigor should involve an evaluation of our current assumptions about ineligibility and the neonatologist's role in providing equipoise in end-of-life decisions regardless of a family's knowledge of (or request to participate in) organ donation.
Conclusions
We found that many neonates who die in the NICU would be eligible to participate in DCDD. Application of these results to other NICUs with similar populations could increase organ and tissue donation substantially and on a national level at a time of progressively increasing transplant wait lists among children and adults. At present, a significant disconnect exists between donor potential and the identification and timely OPO referral that ultimately lead to successful transplants. Improved education of NICU practitioners and staff regarding the process of OPO referral will likely improve the potential opportunities for families to participate in organ donation.
